SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form CORRESP - Correspondence:
SEC Accession No. 0001193125-14-012003
Filing Date
2014-01-15
Accepted
2014-01-15 15:45:35
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 5675
2 GRAPHIC g615506pic-001.jpg GRAPHIC 6456
  Complete submission text file 0001193125-14-012003.txt   15800
Mailing Address 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803
Business Address 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803 617-513-9882
Aldexa Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations